[144] UFP Technologies Inc SEC Filing

Rhea-AI Filing Summary

Form 144 notice for UFP Technologies Inc. (UFPT) shows a proposed sale of 2,873 shares of common stock through UBS Financial Services with an aggregate market value of $591,883. The shares represent part of the company's listed outstanding shares of 7,711,126 and the proposed approximate sale date is 09/05/2025 on NASDAQ.

The filing discloses the acquisition history for the shares to be sold: 1,318 shares were acquired by exercising options on 08/07/2025 (paid in cash), and the remainder came from vesting of stock unit awards on 05/31/2022 (610 shares), 05/31/2023 (647 shares), and 05/31/2024 (298 shares) with the awards treated as compensation. The filer reports no sales of issuer securities in the past three months.

Positive

• Transparent disclosure of broker, share count, aggregate market value, and acquisition history
• No sales reported in the past three months, indicating this proposed sale is not part of a recent selling pattern
• Payment sources specified: cash for option exercise and compensation treatment for vested awards

Negative

• Filer relationship to issuer not specified in the provided extract, limiting context about insider status
• No trading-plan date disclosed (if applicable), which would clarify whether sales align with a 10b5-1 plan

Insights

Financial Analyst

TL;DR Proposed sale equals 2,873 UFPT shares valued at $591,883; acquisition largely from option exercise and vested awards.

The filing is a routine Form 144 notice that documents a planned sale by a person whose holdings include recently exercised options and previously vested restricted stock units. The aggregate value reported, $591,883, is a straightforward disclosure of the intended transaction size relative to the company's outstanding shares (7,711,126). There are no reported sales in the prior three months, and payment sources are specified (cash for the option exercise; compensation for vested awards). This notice alone provides limited insight into company fundamentals or near-term market impact.

Corporate Governance Expert

TL;DR This is a standard insider sale notice showing option exercise plus vesting-related sales; no adverse governance flags disclosed.

The document meets Rule 144 disclosure requirements by identifying the broker, share counts, acquisition dates, and nature of acquisition (option exercise and vesting). It includes the filer’s representation about absence of undisclosed material adverse information. The filing does not include the filer’s relationship to the issuer or any trading-plan adoption date; those details are either omitted or not provided in this extract, limiting assessment of timing motives or compliance with any 10b5-1 plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	2873	591883	7711126	09/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/07/2025	Exercise of Option	Issuer			1318	08/07/2025	Cash
Common Stock	05/31/2022	Vesting of Stock Unit Award	Issuer			610	05/31/2022	Compensation
Common Stock	05/31/2023	Vesting of Stock Unit Award	Issuer			647	05/31/2023	compensation
Common Stock	05/31/2024	Vesting of Stock Unit Award	Issuer			298	05/31/2024	compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for UFPT disclose about the proposed sale?

The filer intends to sell 2,873 common shares through UBS Financial Services on NASDAQ with an aggregate market value of $591,883 and approximate sale date 09/05/2025.

How were the shares being sold acquired according to the filing?

1,318 shares from an option exercise on 08/07/2025 (paid in cash) and 1,555 shares from vesting of stock unit awards on 05/31/2022, 05/31/2023, and 05/31/2024 (treated as compensation).

Does the filing show any sales of UFPT securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed UFPT share sale?

UBS Financial Services Inc. at 1000 Harbor Blvd, Weehawken, NJ is listed as the broker for the transaction.

What is the total number of UFPT shares outstanding reported in the filing?

The filing reports 7,711,126 shares outstanding for the issuer.